Published in Eur Urol on January 16, 2007
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol (2008) 1.54
Quality criteria of laparoscopic nephroureterectomy. Eur Urol (2007) 1.07
Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up. World J Urol (2008) 1.05
Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. World J Surg Oncol (2008) 0.98
Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol (2008) 0.90
Laparoscopic nephroureterectomy and management of the distal ureter: a review of current techniques and outcomes. Adv Urol (2009) 0.86
Ureteroscopic laser treatment of upper urinary tract neoplasms. World J Urol (2010) 0.80
Laparoscopic nephroureterectomy: oncologic outcomes and management of distal ureter; review of the literature. Adv Urol (2008) 0.77
Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours. World J Urol (2012) 0.75
Rebuttal from authors re: Peter Albers. Quality criteria of laparoscopic nephroureterectomy. Eur Urol. 2007;51:1481-2. Eur Urol (2007) 0.75
Systematic review of open versus laparoscopic versus robot-assisted nephroureterectomy. Rev Urol (2017) 0.75
Complications after prostate biopsy: data from SEER-Medicare. J Urol (2011) 5.40
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol (2007) 5.24
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell (2002) 5.10
African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol (2013) 4.20
Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol (2012) 4.11
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes Cancer (2010) 3.78
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer (2011) 3.13
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev (2002) 3.12
Off-clamp versus complete hilar control laparoscopic partial nephrectomy: comparison by clinical stage. BJU Int (2011) 2.97
Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol (2009) 2.76
Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind). J Urol (2013) 2.76
Increased intra-abdominal fat predicts perioperative complications following minimally invasive partial nephrectomy. Urology (2013) 2.70
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst (2005) 2.70
Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol (2009) 2.68
Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol (2011) 2.55
Nerve-sparing laparoscopic radical prostatectomy: replicating the open surgical technique. Urology (2004) 2.29
Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol (2010) 2.28
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology (2010) 2.27
Comparative analysis of minimally invasive partial nephrectomy techniques in the treatment of localized renal tumors. Urology (2012) 2.22
Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol (2009) 2.18
A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol (2011) 2.11
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy. Urology (2013) 2.11
Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology (2009) 2.10
Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging. J Urol (2009) 2.09
Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations. J Endourol (2010) 2.07
Robotic-assisted versus traditional laparoscopic partial nephrectomy: comparison of outcomes and evaluation of learning curve. Urology (2011) 1.98
Primary carcinoid tumors of the kidney. J Urol (2006) 1.86
Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater. Urology (2011) 1.80
Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis. Cancer Res (2007) 1.76
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am J Surg Pathol (2011) 1.76
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy. Eur Urol (2007) 1.72
Recent trends in the urology workforce in the United States. Urology (2013) 1.70
The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol (2009) 1.70
Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome. J Urol (2004) 1.70
Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases. Mod Pathol (2007) 1.67
Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more. J Urol (2009) 1.65
Laparoscopic pyeloplasty: current status. BJU Int (2005) 1.64
Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J Urol (2010) 1.64
Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers. Urology (2013) 1.63
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann Surg (2004) 1.63
Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant (2003) 1.62
Laparoscopic pyeloplasty: the first 100 cases. J Urol (2002) 1.60
Laparoendoscopic single-site pfannenstiel donor nephrectomy. Urology (2009) 1.60
Transmesenteric laparoscopic pyeloplasty. J Urol (2006) 1.57
Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. BJU Int (2014) 1.55
Perioperative outcomes of off-clamp vs complete hilar control laparoscopic partial nephrectomy. BJU Int (2012) 1.54
Complications of 2,775 urological laparoscopic procedures: 1993 to 2005. J Urol (2007) 1.53
Making ends meet: a cost comparison of laparoscopic and open radical retropubic prostatectomy. J Urol (2004) 1.53
Molecular effects of genistein on male urethral development. J Urol (2011) 1.51
Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging. Urology (2011) 1.51
Long-term survival analysis after laparoscopic radical nephrectomy. J Urol (2005) 1.50
Comparison of perioperative outcomes of robot-assisted partial nephrectomy and open partial nephrectomy in patients with a solitary kidney. J Endourol (2014) 1.50
What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology (2009) 1.49
High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy. J Urol (2008) 1.49
R.E.N.A.L. nephrometry score accurately predicts complications following laparoscopic renal cryoablation. J Urol (2012) 1.49
Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy. BJU Int (2009) 1.49
Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer. BJU Int (2013) 1.48
The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol (2011) 1.48
Do fibrin sealants impact negative outcomes after robot-assisted partial nephrectomy? J Endourol (2013) 1.48
Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses. BJU Int (2012) 1.47
Health related quality of life before and after laparoscopic radical prostatectomy. J Urol (2005) 1.47
Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology (2013) 1.47
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience. J Urol (2011) 1.46
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience. Prostate (2013) 1.46
Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology (2007) 1.46
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol (2015) 1.45
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer. BJU Int (2012) 1.44
Laparoscopic partial nephrectomy: effect of warm ischemia on serum creatinine. J Urol (2004) 1.44
Vena caval transection during retroperitoneoscopic nephrectomy: report of the complication and review of the literature. J Urol (2004) 1.43
p53 predictive value for pT1-2 N0 disease at radical cystectomy. J Urol (2009) 1.43
A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings. J Gen Intern Med (2015) 1.43
Laparoscopic-assisted nephroureterectomy after radical cystectomy for transitional cell carcinoma. Int Braz J Urol (2007) 1.42
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience. BJU Int (2013) 1.42
Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol (2012) 1.42
Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. J Urol (2006) 1.40
Audio and visual analysis of urologic laparoscopic and robotic skills: objective criteria for surgical skill evaluation. Urology (2012) 1.40
Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer. Cancer (2014) 1.40
Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol (2005) 1.40
Urology resident experience with an elective in interventional radiology: a pilot evaluation. J Endourol (2012) 1.39
Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors. Urology (2012) 1.39